Rapamycin downregulates α-klotho in the kidneys of female rats with normal and reduced renal function
Open Access
- 28 November 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0294791
Abstract
Both mTOR and α-klotho play a role in the pathophysiology of renal disease, influence mineral metabolism and participate in the aging process. The influence of mTOR inhibition by rapamycin on renal α-klotho expression is unknown. Rats with normal (controls) and reduced (Nx) renal function were treated with rapamycin, 1.3 mg/kg/day, for 22 days. The experiments were conducted with rats fed 0.6% P diet (NP) and 0.2% P diet (LP). Treatment with rapamycin promoted phosphaturia in control and Nx rats fed NP and LP. A decrease in FGF23 was identified in controls after treatment with rapamycin. In rats fed NP, rapamycin decreased mRNA α-klotho/GADPH ratio both in controls, 0.6±0.1 vs 1.1±0.1, p = 0.001, and Nx, 0.3±0.1 vs 0.7±0.1, p = 0.01. At the protein level, a significant reduction in α-klotho was evidenced after treatment with rapamycin both by Western Blot: 0.6±0.1 vs 1.0±0.1, p = 0.01, in controls, 0.7±0.1 vs 1.1±0.1, p = 0.02, in Nx; and by immunohistochemistry staining. Renal α-klotho was inversely correlated with urinary P excretion (r = -0.525, p = 0.0002). The decrease in α-klotho after treatment with rapamycin was also observed in rats fed LP. In conclusion, rapamycin increases phosphaturia and down-regulates α-klotho expression in rats with normal and decreased renal function. These effects can be observed in animals ingesting normal and low P diet.Keywords
Funding Information
- Instituto de Salud Carlos III (PI21/00269)
This publication has 32 references indexed in Scilit:
- Phosphate is a vascular toxinPediatric Nephrology, 2012
- Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in ratsBritish Journal of Pharmacology, 2011
- Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho ExpressionAmerican Journal of Transplantation, 2011
- Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubuleThe FASEB Journal, 2010
- Rapamycin-induced phosphaturiaNephrology Dialysis Transplantation, 2010
- Klotho converts canonical FGF receptor into a specific receptor for FGF23Nature, 2006
- Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in RatsJournal of the American Society of Nephrology, 2006
- Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKBMolecular Cell, 2006
- Suppression of Aging in Mice by the Hormone KlothoScience, 2005
- Mechanism of action of the immunosuppressant rapamycinLife Sciences, 1995